{"id":6240,"date":"2025-05-07T12:16:39","date_gmt":"2025-05-07T17:16:39","guid":{"rendered":"https:\/\/lsom.uthscsa.edu\/family-medicine\/?page_id=6240"},"modified":"2025-05-12T08:59:39","modified_gmt":"2025-05-12T13:59:39","slug":"direct-oral-anticoagulants-doacs-a-primer-for-physicians","status":"publish","type":"page","link":"https:\/\/lsom.uthscsa.edu\/family-medicine\/direct-oral-anticoagulants-doacs-a-primer-for-physicians\/","title":{"rendered":"Direct Oral Anticoagulants (DOACs): A Primer for Physicians"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row][vc_column width=&#8221;2\/3&#8243;][vc_column_text css=&#8221;&#8221;]<\/p>\n<h3>Overview:<\/h3>\n<p><strong>Direct Oral Anticoagulants (DOACs): A Primer for Physicians<\/strong><\/p>\n<p><strong>Hien Ha, PharmD, BCPS<\/strong><\/p>\n<p>This presentation will review the clinical therapeutics of direct oral anticoagulants (DOACs). It will highlight basic concepts including primary indications, dosing, drug interactions, and monitoring. It will also review recommendations on transition between anticoagulants, periprocedural management of DOACs, and DOAC-associated bleeding.<\/p>\n<p>After this presentation, attendees will be able to:<\/p>\n<ol>\n<li>Summarize the basic pharmacology of DOACs.<\/li>\n<li>Describe the primary indications, dosing, drug interactions, and monitoring for DOACs.<\/li>\n<li>Outline important considerations when selecting DOACs for a patient.<\/li>\n<li>Explain current recommendations surrounding the transition between DOACs, periprocedural management of DOACs, and DOAC- associated bleeding.<\/li>\n<\/ol>\n<h3>Presenter:<\/h3>\n<p><strong><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-6241 size-full\" src=\"https:\/\/lsom.uthscsa.edu\/family-medicine\/wp-content\/uploads\/sites\/75\/2025\/05\/ha.png\" alt=\"\" width=\"204\" height=\"243\" \/><\/strong><\/p>\n<p><strong>Hien Ha, PharmD, BCPS<\/strong><br \/>\nAssociate Professor in Pharmacy Practice, UIW Feik School of Pharmacy<\/p>\n<p>&nbsp;<\/p>\n<h3>Financial Disclosures:<\/h3>\n<p>Hien Ha, PharmD has no financial relationships with ineligible companies to disclose.<\/p>\n<p>The Family &amp; Community Medicine Professional Development and Grand Rounds Committee members (Maria Del Pilar Montanez Villacampa, MD, Stacy Ogbeide, PsyD; Yun Shi, MD, PhD; Mark Nadeau, MD, MBA; Fozia Ali, MD; Christine Camacho, MD; Richel Avery, MD; Nehman Andry, MD; Angelica Davila, MD; Nida Hussain, MD; Neil Sood, DO) have no financial relationships with ineligible companies to disclose.<\/p>\n<p>&nbsp;<\/p>\n<h3>Credits:<\/h3>\n<p><em>AMA PRA Category 1 Credits\u2122<\/em> (1.00 hours), Non-Physician Participation Credit (1.00 hours)<\/p>\n<h3>Target Audience:<\/h3>\n<p>Specialties \u2013 Primary Care; Family Medicine<br \/>\nFaculty, residents, other health care providers and staff from our department; physicians and health care providers from San Antonio and South Texas; and medical students in our third-year clerkship and fourth year rotations.<\/p>\n<h3>Accreditation:<\/h3>\n<p>The UT Health Science Center San Antonio is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.<\/p>\n<h3>Credit Designation:<\/h3>\n<p>The UT Health Science Center San Antonio designates this live activity up to a maximum of\u00a0<em>1.00 AMA PRA Category 1 Credits\u2122<\/em>.<\/p>\n<p>Physicians should claim only the credit commensurate with the extent of their participation in the activity.<\/p>\n<p>Nurses and other healthcare professionals will receive a Certificate of Attendance. For information on applicability and acceptance, please consult your professional licensing board.[\/vc_column_text][\/vc_column][vc_column width=&#8221;1\/3&#8243;] \n        <a class=\"panel no-equilizer panel-mobile text-center colorized colorized-institutional\" href=\"https:\/\/cmetracker.net\/UTHSCSA\/Publisher?page=pubOpen#\/EventID\/10098686\" title=\"Direct Oral Anticoagulants (DOACs): A Primer for Physicians (CME)\" target=\"_blank\">\n            <span class=\"circle close2x mid-icon\"><span><i class=\"icon-checkbox-checked\"><\/i><\/span><\/span><br>\n            <h3 >View Recording (CME Credit)<\/h3>\n            <p><\/p>\n        <\/a> \n        <a class=\"panel no-equilizer panel-mobile text-center colorized colorized-academics\" href=\"https:\/\/www.youtube.com\/watch?v=GNWPINbTLiY\" title=\"Direct Oral Anticoagulants (DOACs): A Primer for Physicians\" target=\"_blank\">\n            <span class=\"circle close2x mid-icon\"><span><i class=\"icon-uth-shield\"><\/i><\/span><\/span><br>\n            <h3 >View Recording (no CME Credit)<\/h3>\n            <p><\/p>\n        <\/a>[vc_column_text css=&#8221;&#8221;]For activity related questions, please contact:<br \/>\nName: Kelsi Sexton Barajas- TAFP FCM Grand Rounds Coordinator<br \/>\nEmail: <a href=\"mailto:sextonk@uthscsa.edu\">sextonk@uthscsa.edu<\/a><\/p>\n<p>For CME general questions, please contact<br \/>\nPh: (210) 567-4445<br \/>\nEmail: <a href=\"mailto:cme@uthscsa.edu\">cme@uthscsa.edu<\/a>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column width=&#8221;2\/3&#8243;][vc_column_text css=&#8221;&#8221;] Overview: Direct Oral Anticoagulants (DOACs): A Primer for Physicians Hien Ha, PharmD, BCPS This presentation will review the clinical therapeutics of direct oral anticoagulants (DOACs). It will highlight basic concepts including primary indications, dosing, drug interactions, and monitoring. It will also review recommendations on transition between anticoagulants, periprocedural management of DOACs, and [&hellip;]<\/p>\n","protected":false},"author":477,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-6240","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Direct Oral Anticoagulants (DOACs): A Primer for Physicians - Family and Community Medicine<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/lsom.uthscsa.edu\/family-medicine\/direct-oral-anticoagulants-doacs-a-primer-for-physicians\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Direct Oral Anticoagulants (DOACs): A Primer for Physicians - Family and Community Medicine\" \/>\n<meta property=\"og:description\" content=\"[vc_row][vc_column width=&#8221;2\/3&#8243;][vc_column_text css=&#8221;&#8221;] Overview: Direct Oral Anticoagulants (DOACs): A Primer for Physicians Hien Ha, PharmD, BCPS This presentation will review the clinical therapeutics of direct oral anticoagulants (DOACs). It will highlight basic concepts including primary indications, dosing, drug interactions, and monitoring. It will also review recommendations on transition between anticoagulants, periprocedural management of DOACs, and [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/lsom.uthscsa.edu\/family-medicine\/direct-oral-anticoagulants-doacs-a-primer-for-physicians\/\" \/>\n<meta property=\"og:site_name\" content=\"Family and Community Medicine\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-12T13:59:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/lsom.uthscsa.edu\/family-medicine\/wp-content\/uploads\/sites\/75\/2025\/05\/ha.png\" \/>\n\t<meta property=\"og:image:width\" content=\"204\" \/>\n\t<meta property=\"og:image:height\" content=\"243\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/family-medicine\\\/direct-oral-anticoagulants-doacs-a-primer-for-physicians\\\/\",\"url\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/family-medicine\\\/direct-oral-anticoagulants-doacs-a-primer-for-physicians\\\/\",\"name\":\"Direct Oral Anticoagulants (DOACs): A Primer for Physicians - Family and Community Medicine\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/family-medicine\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/family-medicine\\\/direct-oral-anticoagulants-doacs-a-primer-for-physicians\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/family-medicine\\\/direct-oral-anticoagulants-doacs-a-primer-for-physicians\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/family-medicine\\\/wp-content\\\/uploads\\\/sites\\\/75\\\/2025\\\/05\\\/ha.png\",\"datePublished\":\"2025-05-07T17:16:39+00:00\",\"dateModified\":\"2025-05-12T13:59:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/family-medicine\\\/direct-oral-anticoagulants-doacs-a-primer-for-physicians\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/lsom.uthscsa.edu\\\/family-medicine\\\/direct-oral-anticoagulants-doacs-a-primer-for-physicians\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/family-medicine\\\/direct-oral-anticoagulants-doacs-a-primer-for-physicians\\\/#primaryimage\",\"url\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/family-medicine\\\/wp-content\\\/uploads\\\/sites\\\/75\\\/2025\\\/05\\\/ha.png\",\"contentUrl\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/family-medicine\\\/wp-content\\\/uploads\\\/sites\\\/75\\\/2025\\\/05\\\/ha.png\",\"width\":204,\"height\":243},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/family-medicine\\\/direct-oral-anticoagulants-doacs-a-primer-for-physicians\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/family-medicine\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Direct Oral Anticoagulants (DOACs): A Primer for Physicians\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/family-medicine\\\/#website\",\"url\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/family-medicine\\\/\",\"name\":\"Family and Community Medicine\",\"description\":\"Department of Family &amp; Community Medicine\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/family-medicine\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Direct Oral Anticoagulants (DOACs): A Primer for Physicians - Family and Community Medicine","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/lsom.uthscsa.edu\/family-medicine\/direct-oral-anticoagulants-doacs-a-primer-for-physicians\/","og_locale":"en_US","og_type":"article","og_title":"Direct Oral Anticoagulants (DOACs): A Primer for Physicians - Family and Community Medicine","og_description":"[vc_row][vc_column width=&#8221;2\/3&#8243;][vc_column_text css=&#8221;&#8221;] Overview: Direct Oral Anticoagulants (DOACs): A Primer for Physicians Hien Ha, PharmD, BCPS This presentation will review the clinical therapeutics of direct oral anticoagulants (DOACs). It will highlight basic concepts including primary indications, dosing, drug interactions, and monitoring. It will also review recommendations on transition between anticoagulants, periprocedural management of DOACs, and [&hellip;]","og_url":"https:\/\/lsom.uthscsa.edu\/family-medicine\/direct-oral-anticoagulants-doacs-a-primer-for-physicians\/","og_site_name":"Family and Community Medicine","article_modified_time":"2025-05-12T13:59:39+00:00","og_image":[{"width":204,"height":243,"url":"https:\/\/lsom.uthscsa.edu\/family-medicine\/wp-content\/uploads\/sites\/75\/2025\/05\/ha.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/lsom.uthscsa.edu\/family-medicine\/direct-oral-anticoagulants-doacs-a-primer-for-physicians\/","url":"https:\/\/lsom.uthscsa.edu\/family-medicine\/direct-oral-anticoagulants-doacs-a-primer-for-physicians\/","name":"Direct Oral Anticoagulants (DOACs): A Primer for Physicians - Family and Community Medicine","isPartOf":{"@id":"https:\/\/lsom.uthscsa.edu\/family-medicine\/#website"},"primaryImageOfPage":{"@id":"https:\/\/lsom.uthscsa.edu\/family-medicine\/direct-oral-anticoagulants-doacs-a-primer-for-physicians\/#primaryimage"},"image":{"@id":"https:\/\/lsom.uthscsa.edu\/family-medicine\/direct-oral-anticoagulants-doacs-a-primer-for-physicians\/#primaryimage"},"thumbnailUrl":"https:\/\/lsom.uthscsa.edu\/family-medicine\/wp-content\/uploads\/sites\/75\/2025\/05\/ha.png","datePublished":"2025-05-07T17:16:39+00:00","dateModified":"2025-05-12T13:59:39+00:00","breadcrumb":{"@id":"https:\/\/lsom.uthscsa.edu\/family-medicine\/direct-oral-anticoagulants-doacs-a-primer-for-physicians\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/lsom.uthscsa.edu\/family-medicine\/direct-oral-anticoagulants-doacs-a-primer-for-physicians\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/lsom.uthscsa.edu\/family-medicine\/direct-oral-anticoagulants-doacs-a-primer-for-physicians\/#primaryimage","url":"https:\/\/lsom.uthscsa.edu\/family-medicine\/wp-content\/uploads\/sites\/75\/2025\/05\/ha.png","contentUrl":"https:\/\/lsom.uthscsa.edu\/family-medicine\/wp-content\/uploads\/sites\/75\/2025\/05\/ha.png","width":204,"height":243},{"@type":"BreadcrumbList","@id":"https:\/\/lsom.uthscsa.edu\/family-medicine\/direct-oral-anticoagulants-doacs-a-primer-for-physicians\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/lsom.uthscsa.edu\/family-medicine\/"},{"@type":"ListItem","position":2,"name":"Direct Oral Anticoagulants (DOACs): A Primer for Physicians"}]},{"@type":"WebSite","@id":"https:\/\/lsom.uthscsa.edu\/family-medicine\/#website","url":"https:\/\/lsom.uthscsa.edu\/family-medicine\/","name":"Family and Community Medicine","description":"Department of Family &amp; Community Medicine","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/lsom.uthscsa.edu\/family-medicine\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/lsom.uthscsa.edu\/family-medicine\/wp-json\/wp\/v2\/pages\/6240","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lsom.uthscsa.edu\/family-medicine\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/lsom.uthscsa.edu\/family-medicine\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/lsom.uthscsa.edu\/family-medicine\/wp-json\/wp\/v2\/users\/477"}],"replies":[{"embeddable":true,"href":"https:\/\/lsom.uthscsa.edu\/family-medicine\/wp-json\/wp\/v2\/comments?post=6240"}],"version-history":[{"count":0,"href":"https:\/\/lsom.uthscsa.edu\/family-medicine\/wp-json\/wp\/v2\/pages\/6240\/revisions"}],"wp:attachment":[{"href":"https:\/\/lsom.uthscsa.edu\/family-medicine\/wp-json\/wp\/v2\/media?parent=6240"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}